knowledge -WSS

knowledge

author：focus 2025-09-02 11:47:57 - browse：75

A doctor climbs up a red ladder to a vine shaped like a DNA — biotech coverage from STAT — Adobe

Every morning, Victoria Rasberry gets up before 6 a.m., walks to the bedroom down the hall, and helps her 8-year-old daughter Addi slide into a set of contraptions that squeeze and suck out the thick mucus constantly threatening to choke her airways closed. She feeds Addi breakfast through a stomach tube and makes sure she has the right mix of the 28 different medications required to keep her free of pain, infections, and seizures. At some point, Rasberry’s five other children will wake up and start to get ready for school, including her youngest, Oliver. At 3-and-a-half years old, he’s a typical toddler — always running and giggling and getting into things. You would never know that he and Addi were born with the same mutation lurking in their DNA, a genetic glitch that causes a fatal neurodegenerative disease called metachromatic leukodystrophy, or MLD.

“When Addi was this age she had lost the ability to speak and was already using a ventilator to sleep at night,” Rasberry said. “It’s amazing to see how well Ollie is doing in comparison. And it’s all because of the gene therapy.”

Three years ago, when Ollie was just 6 months old, he and Victoria traveled from their home in Texas to Milan, to receive a gene therapy treatment that adds a healthy version of the defective gene into patients’ own stem cells. At the time, traveling abroad for the therapy, which is manufactured by Orchard Therapeutics and was approved in Europe in 2021, was the only option for families stricken by MLD. But soon it will be available in the U.S., too.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Cord blood banking comes at a high cost to babies

WSS

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

FDA approves first blood sugar monitor without finger pricks

How to protect coverage of PrEP

Novartis develops a rapidly manufactured CAR

Thousands protest mob assault of women who were paraded naked in remote Indian border state

Let's speed up science by embracing open access publishing

knowledge

knowledge

focus

In age of alternative facts, a scholarly course on calling out crap

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Cancer drug shortages should be causing more outrage

ASCO: Palliative care found as helpful given virtually as in person

Supreme Court strikes down use of affirmative action

FDA approves first blood sugar monitor without finger pricks

Peter Hotez and the public health issue of online harassment

Where does female orgasm come from? Scientists think they know

Moonlake's readout produced a cash windfall. Risks remain

Novartis develops a rapidly manufactured CAR

Wikipedia

Let's speed up science by embracing open access publishing

How a key Senate committee is planning to regulate PBMs

Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

Clinic falsely told dozens they had Alzheimer's, suits say

How a key Senate committee is planning to regulate PBMs

Novartis develops a rapidly manufactured CAR

leisure time

hotspot

Wikipedia

focus